1.CapitalBio Technology built the health - related products manufacturing facilities in Chongqing.
4.CapitalBio Technology’s ‘LeiJingTang’ Health Management Center was opened in Pudong, Shanghai.
1.Won the title of “National Intellectual Property Model Enterprise”.
6.CapitalBio Technology’s Sclera Imaging System won China’s Red Star Design Award.
9.The Livestock and Poultry Breeding Branch Center of NERCBBT was established in Beijing.
4.CapitalBio Technology’s HPV Genotyping Detection Kit (microarray) was approved by CFDA.
5.Yantai branch-center of NERCBBT was officially established.
5. Branch-centers in Ningbo, Ningxia, Shanxi and Xinjiang were granted with the name plate by NDRC.
1.Genetic Screening Program of Inherited Hearing Loss for the deaf in Beijing was accomplished.
1.CapitalBio’s M. tuberculosis Drug Resistance Detection Kit (microarray) was approved by CFDA.
3.CapitalBio’s high-throughput microarray scanner LuxScanTM HT 24 was launched.
5.CapitalBio’s Mycobacterial Species Identification Kit (microarray) was approved by CFDA.
3.CapitalBio’s Auto-antibody (eight items) Detection Kit (microarray) was approved by CFDA.
4.CapitalBio’s Nine Deafness Gene Mutations Detection Kit (microarray) was approved by CFDA.
1.ISO9001 and ISO13485 certificates was issued.
2.CapitalBio’s laser confocal scanner LuxScanTM 10 KB was approved by CFDA.
1.CapitalBio’s first CCD-based microarray scanner EcoScanTM-100 was approved by CFDA.
2.China’s first laser confocal scanner LuxScanTM 10K exported to the United States of America.
Copyright © 2000-2023博奥生物集团有限公司 京ICP备14023013号-3
《互联网药品信息服务资格证书》: (京) - 非经营性-2016-0047 京公网安备11011402013114号